Appinventiv Call Button

Appinventiv Accelerates EU Market Access for HealthTech Innovators with Its MDR Compliance Framework

Appinventiv Technologies July 16, 2025
EU MDR Compliance for Medical Devices

July 16, 2025 – Appinventiv, a global leader in digital engineering for regulated industries, announced the launch of its end-to-end compliance framework for the European Union’s Medical Device Regulation (MDR – EU 2017/745). This comprehensive service is designed to guide medical device software (MDSW), AI-driven diagnostics, and health wearable companies through the complexities of achieving and maintaining CE marking for the EU market.

The framework provides a clear, strategic pathway for innovators to ensure their products meet the EU’s rigorous standards for safety, performance, and traceability. Drawing on experience from over 200 healthcare solutions, our approach transforms regulatory hurdles into a competitive advantage, enabling clients to strengthen their global presence and build unshakable trust with patients and providers.

Our Strategic Approach to the EU’s MDR Compliance

As experts in navigating complex regulatory paths for both Fortune 500 companies and innovative startups, our strategy is unique, based on transparency, recognized industry best practices, and a strong focus on compliance, prioritizing patient safety and data integrity. Important components of our evidence-based MDR compliance framework include:

  1. Correct Classifications of the Device: Our certified regulatory specialists conduct a detailed analysis of the software in compliance with MDR Annex VIII and Rule 11 to provide the proper classification (Class I, IIa, IIb, or III). This reduces the unknowns of costly reclassification and complies with the MDCG 2019-11.
  2. QMS that is ISO 13485 compliant: We build and implement quality management system (QMS) frameworks that incorporate risk management (ISO 14971) and a software lifecycle process regulated by IEC 62304. This provides a recourse to ensure adherence to finding consistent software quality, readiness for annual audits, and satisfaction of Article 10(2) requirements.
  3. Comprehensive Technical Documentation: It encompasses patient and technical specifications of the device, risk management, clinical evaluations, and usability evaluations as outlined in Annexes II and III.
  4. Clinical Evaluations that meet or exceed Article 61: By utilizing a clinical study or non-clinical data, we can develop compliance solutions that are more robust in providing evidence that the software meets safety and performance requirements.
  5. EUDAMED and UDI: We help ensure devices have a UID assigned and registered in the EUDAMED for traceability and transparency as part of the MDR regulations.
  6. Proactive Post-Market Surveillance (PMS): We develop PMS systems for ongoing surveillance, reporting, and PMS activities, such as component Periodic Safety Update Reports (PSURs) and reports of vigilance, to ensure ongoing regulatory compliance and market sustainability.
  7. Planning for Transitional Timelines: The transition periods for MDR are longer for legacy devices (2026–2028). We build a compliance roadmap to avoid disruptions during your transition and maintain ongoing service.
  8. Assistance with Economic Operator Role: We provide in-depth guidance on our clients’ obligations as manufacturers, importers, and authorized representatives, as per Article 15, in collaboration with the appointed Person Responsible for Regulatory Compliance (PRRC).

Driving Global Healthcare Impact

Our MDR compliance expertise provides measurable benefits, allowing clients to achieve compliance and more:

  1. Strategic EU Market Access: By obtaining CE marking, we can provide access to the 27 member states of the European Economic Area (EEA) while aligning with global standards in recognized regions, such as Asia and the Middle East.
  2. Increased Trust and Credibility: Our EU MDR compliance enhances trust among organizations, healthcare providers, patients, and regulators, distinguishing clients as leaders in their industry.
  3. Accelerated Time-to-Market: We help accelerate the launch of a product through our defined processes, minimizing any potential delays arising from Notified Body audits. This competitive advantage enables our clients to enter the market with their solutions much faster.
  4. Innovation Enablement: By addressing MDR requirements for emerging technologies such as AI, IoT, and XR, we enable our clients to develop cutting-edge solutions without compromising compliance.
  5. Sustained Growth: Our PMS and QMS frameworks are intentionally designed to maintain long-term compliance, enabling our clients to scale their products and keep their market position.

Proven Client Success

With our experience, we have already changed the course of history for many healthcare innovators. One of our recent clients, a start-up that was developing a telehealth app for chronic disease monitoring, enlisted our help to obtain MDR compliance. We classified their app as Class IIa under rule 11, developed an ISO 13485 compliant QMS, conducted multiple clinical evaluations, and registered their app in EUDAMED. And what was the result? The app received CE marking within six months, enabling market access in the EU and enhancing the client’s credibility in North America and Asia.

“I’m proud to lead our efforts in helping clients meet EU Medical Device Regulation standards. We simplify compliance for healthcare innovations, such as telehealth apps and AI diagnostics, ensuring they’re safe, reliable, and market-ready. Our clear processes and focus on quality help clients gain EU approval, build trust, and grow globally with confidence,” said Appinventiv’s VP of Compliance & Security.

About Appinventiv

As a global leader in healthcare software development, Appinventiv has executed over 3,000 projects for clients worldwide that meet HIPAA, HITECH, GDPR, MDR, and HL7 standards. Appinventiv employs over 1,600 specialists in healthcare development and has established itself as a leader in health technology innovation through the use of AI, IoT, and Blockchain-based solutions that power our Health software user experiences, from telemedicine platforms to EHR systems, facilitating better patient care and improving workflows.

Appinventiv
THE AUTHOR
Appinventiv Technologies
Prev PostNext Post
Read More Press Releases
Appinventiv Deloitte

Appinventiv, an emerging global leader in the IT space, has unlocked rapid yet steady revenue growth through its innovative and scalable digital transformation solutions. As a result, the company has secured the winning spotlight in the Deloitte Technology Fast 50 India 2023 Programme, joining the league of the top 50 fastest-growing tech companies in India. From 57.4 Cr in…

Appinventiv Technologies

Clutch has recognized Appinventiv among the top 24 leading mobile app development companies, globally. After recognizing the company as the top Android app developers and top iOS app developers in India, now the leading market analysis and reporting agency has ranked Appinventiv as the eminent leader in App Development, internationally as well. Clutch analyzed 477 companies across six industries…

Appinventiv Technologies
Appinventiv Databricks Partnership

Noida, India – August 14, 2025 – Appinventiv, a global leader in digital transformation and innovative technology solutions, is proud to announce the significant enhancement of our data security services through our Premier Partnership with Databricks, the Data and AI company. This strategic collaboration empowers us to deliver a new echelon of data protection, governance,…

Appinventiv Technologies